Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effects of topically administered neuroprotective drugs in early stages of diabetic retinopathy: Results of the EUROCONDOR clinical trial

Autor: Simo, Rafael, Hernandez, Cristina, Porta, Massimo, Bandello, Francesco, Grauslund, Jakob, Harding, Simon P, Aldington, Stephen J, Egan, Catherine, Frydkjaer-Olsen, Ulrik, Garcia-Arumi, Jose, Gibson, Jonathan, Lang, Gabriele E, Lattanzio, Rosangela, Massin, Pascale, Midena, Edoardo, Ponsati, Berta, Ribeiro, Luisa, Scanlon, Peter, Lobo, Conceicao, Costa, Miguel Angelo, Cunha-Vaz, Jose, Garcia-Ramirez, M, van Reck, E, Gil, E, Morillas, M, Cunha-Vaz, J, Ribeiro, L, Lobo, C, Costa, MA, Nunes, S, Figueira, J, Pereira-Marques, I, Neves, C, Schwartz, C, Porta, M, Trento, M, Durando, O, Merlo, S, Bandello, F, Lattanzio, R, Zucchiatti, I, Grauslund, J, Frydkjaer-Olsen, U, Harding, SP, Scanlon, P, Aldington, SJ, Jones, V, Johnson, L, Carter, S, Spurway, J, Egan, C, Esposti, S, Leitch-Devlin, L, Rocco, V, Rees, A, Garcia-Arumi, J, Zapata, MA, Boixadera, A, Macia, C, Distefano, L, Torrent, T, Casals, F, de Dios, N, Gibson, J, Lang, GE, Jens-Ulrich, W, Christian, E, Adnan, K, Massin, P, Erginay, A, Midena, E, Vujosevic, S, Pilotto, E, Longhin, E, Convento, E, Ponsati, B, Fernandez-Carneado, J, Arrastia-Casado, S, Orgue, S, Ramirez-Lamelas, DT, Almazan-Moga, A, Salva, A, Riera, L, Treatme, European Consortium Early

Publikováno v: Simó, R, Hernández, C, Porta, M, Bandello, F, Grauslund, J, Harding, S P, Aldington, S J, Egan, C, Frydkjaer-Olsen, U, García-Arumí, J, Gibson, J, Lang, G E, Lattanzio, R, Massin, P, Midena, E, Ponsati, B, Ribeiro, L, Scanlon, P, Lobo, C, Costa, M Â, Cunha-Vaz, J & European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) 2019, ' Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy. Results of the EUROCONDOR Clinical Trial ', Diabetes, vol. 68, no. 2, pp. 457-463 . https://doi.org/10.2337/db18-0682
DIABETES

The primary objective of this study was to assess whether the topical administration of two neuroprotective drugs (brimonidine and somatostatin) could prevent or arrest retinal neurodysfunction in patients with type 2 diabetes. For this purpose, adul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1575fdf8833bf6dfe56383306a0025af

Intravitreal Ranibizumab in Diabetic Macular Edema: Long-Term Outcomes

Autor: Zucchiatti I., Bandello F.

Intravitreal ranibizumab (RBZ) has been shown in multiple randomized clinical trials to be a valuable treatment for diabetic macular edema (DME), promoting a significant improvement in best-corrected visual acuity (BCVA) and in anatomic outcomes. Com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::5ba939e0f517fe5b6e9814c992dfc570

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Caractéristiques à l’angio–CT d’une excavation choroïdienne focale

Autor: Ntomb, J.-P., Carnevali, A., Querques, L., Zucchiatti, I., Bandello, F., Querques, G.

Publikováno v: In Journal Francais d'Ophtalmologie June 2016 39(6):574-576